Skip to main content
Premium Trial:

Request an Annual Quote

Will Molecular Devices Acquisition of Axon Affect Cellectricon?


Cellectricon’s single-cell capillary electroporation technology, ElectroFlow, is used to introduce foreign molecules into individual cells by applying an electrical discharge to the cell membrane. Lindberg told Inside Bioassays that the company is heavily promoting the technology for high-throughput screening using siRNA.

However, like traditional electroporation, the technology can also be used to introduce any impermeable molecules into the cell, such as DNA, RNA, chemical compounds, and molecular probes.

In fact, last October Cellectricon licensed the electroporation technology to Axon Instruments, a potential competitor for Cellectricon’s microfluidics platform for lead optimization screening of ion channels. Axon has in turn incorporated the technology into its Axoporator single-cell electroporation instrument, which the company is marketing primarily as a transfection tool for both screening applications and basic research.

Inside Bioassays asked Lindberg how he thought Molecular Devices’ pending acquisition of Axon would change the nature of this relationship and the cell-based screening market.

“I don’t know for sure — I think very few people do. But what is clear to me is that Molecular Devices has nothing below the 96-well format. Now they get the ImageXpress and PatchXpress. What will happen with the entire neurosciences business — from amplifiers to the lab bench version of a transfection instrument — I don’t know. But for me, it’s pretty clear that it doesn’t fully fit the Molecular Devices portfolio, including the amplifiers and everything for patch clamp.”

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.